Abiopharma

TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

SurgePays Reports Q2 2026 Revenue Growth of 40.7% Year-Over-Year to $16.2 Million, Reports Positive Net Income of $1.29 Million

General Announcement: Quarterly Update (Q2-2026) on the Proceeds raised from the Rights cum Warrants Issue

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

General Announcement: Net Tangible Assets ("NTA") Per Share

Form 8.3

Financial Statements and Related Announcement: Half Yearly Results

Canopy Growth Communication - Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows

Asset Acquisitions and Disposals: DISPOSAL OF SUBSIDIARY